Table 1 Patient characteristics
Total eyes, N | 21 |
Total patients, N | 19 |
Female, N (%) | 11 (58) |
Age, years (range) | 79 (67–95) |
Number of bevacizumab and ranibizumab injections prior to aflibercept, mean (range) | 20.71 (3–49) |
Aflibercept injections, mean (range) | 7.19 (3–14) |
Injection interval in weeks while on aflibercept, mean ± SD | 6.08 ± 1.12 |
Injection interval in weeks between last aflibercept injection and first bevacizumab or ranibizumab injection, mean ± SD | 5.97 ± 3.24 |